相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Po- tential Inhibitors of 2019-novel Coronavirus Main Protease (2019-nCoVMpro), Molecular Docking and SAR Study
Talia Serseg et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Triazavirin- Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Siyamak Shahab et al.
CURRENT MOLECULAR MEDICINE (2021)
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: anin silicobased approach
Saurov Mahanta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
Umesh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Sukanth Kumar Enmozhi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Structure analysis of the receptor binding of 2019-nCoV
Yun Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
Jared S. Morse et al.
CHEMBIOCHEM (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Linlin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
Anas Shamsi et al.
BIOSCIENCE REPORTS (2020)
Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1α-independent VEGF expression and angiogenesis in hepatocellular carcinoma
Cheng Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Inhaled NO and COVID-19
Louis J. Ignarro
BRITISH JOURNAL OF PHARMACOLOGY (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19 in Children: Clinical Approach and Management
Jhuma Sankar et al.
INDIAN JOURNAL OF PEDIATRICS (2020)
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis
Xiu-wu Pan et al.
INTENSIVE CARE MEDICINE (2020)
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
Maria Bzowka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
Andre Fischer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
Aleix Gimeno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TMPRSS2: Potential Biomarker for COVID-19 Outcomes
Jonathan D. Strope et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
Javier A. Jaimes et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs
Paolo Calligari et al.
VIRUSES-BASEL (2020)
In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease
Tien Huynh et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?
Konrad H. Stopsack et al.
CANCER DISCOVERY (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
Motonori Tsuji
FEBS OPEN BIO (2020)
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
Davide Gentile et al.
MARINE DRUGS (2020)
Characterization and Noncovalent Inhibition of the Deubiquitinase and delSGylase Activity of SARS-CoV-2 Papain-Like Protease
Brendan T. Freitas et al.
ACS INFECTIOUS DISEASES (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)
Noor Rahman et al.
MOLECULES (2020)
Potential Effects of Coronaviruses on the Cardiovascular System A Review
Mohammad Madjid et al.
JAMA CARDIOLOGY (2020)
Profile of a killer: the complex biology powering the coronavirus pandemic
David Cyranoski
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Hai-xia Su et al.
ACTA PHARMACOLOGICA SINICA (2020)
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
Hui-Chen Hung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex
Julia Liang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
Li Zou et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations
Mohamed Hagar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
Javier A. Jaimes et al.
ISCIENCE (2020)
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M pro enzyme through in silico approach
Arun Bahadur Gurung et al.
LIFE SCIENCES (2020)
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich et al.
STEM CELL REVIEWS AND REPORTS (2020)
Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication
Mutsuo Yamaya et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Zeljko Reiner et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin
Thuy Van Lam Van et al.
CHEMMEDCHEM (2019)
Structural comparison strengthens the higher-order classification of proteases related to chymotrypsin
Heli A. M. Monttinen et al.
PLOS ONE (2019)
Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage
Muhammad Imran et al.
VIRUSES-BASEL (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
X-ray Structures of the Proprotein Convertase Furin Bound with Substrate Analogue Inhibitors Reveal Substrate Specificity Determinants beyond the S4 Pocket
Sven O. Dahms et al.
BIOCHEMISTRY (2018)
Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
Kazuya Shirato et al.
VIROLOGY (2018)
Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth
Daniel E. Bassi et al.
MOLECULAR CARCINOGENESIS (2017)
A Review on the Phytochemistry, Pharmacology, Pharmacokinetics and Toxicology of Geniposide, a Natural Product
Mingqiu Shan et al.
MOLECULES (2017)
Geniposide Attenuates Post-Ischaemic Neurovascular Damage via GluN2A/AKT/ERK-Dependent Mechanism
Baosheng Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Li Wen Shen et al.
BIOCHIMIE (2017)
Proprotein convertase inhibition: Paralyzing the cell's master switches
Andres J. Klein-Szanto et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin
Kornelia Hardes et al.
CHEMMEDCHEM (2017)
Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor
Sven O. Dahms et al.
ACS CHEMICAL BIOLOGY (2017)
Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism
Sven O. Dahms et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Novel Furin Inhibitors with Potent Anti-infectious Activity
Kornelia Hardes et al.
CHEMMEDCHEM (2015)
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats
O. Guttman et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Therapeutic uses of furin and its inhibitors: a patent review
Frederic Couture et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition
Qin Tang et al.
SCIENTIFIC REPORTS (2015)
Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity
Stefanie Gierer et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
Yahira M. Baez-Santos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
TMPRSS2 Is a Host Factor That Is Essential for Pneumotropism and Pathogenicity of H7N9 Influenza A Virus in Mice
Carolin Tarnow et al.
JOURNAL OF VIROLOGY (2014)
The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses
Kouji Sakai et al.
JOURNAL OF VIROLOGY (2014)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
Hironori Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Jared M. Lucas et al.
CANCER DISCOVERY (2014)
Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
Christine Burkard et al.
PLOS PATHOGENS (2014)
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
Graham Simmons et al.
ANTIVIRAL RESEARCH (2013)
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus
Yan J. Pang et al.
LIVER INTERNATIONAL (2013)
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
Bastian Hatesuer et al.
PLOS PATHOGENS (2013)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes
Diego Sbardella et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
Stephanie Bertram et al.
PLOS ONE (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Selective and potent furin inhibitors protect cells from anthrax without significant toxicity
Albert G. Remacle et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics
Gero L. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2010)
Androgen receptor and androgen-dependent gene expression in lung
Laura Mikkonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The role of furin in papillomavirus infection
Patricia M. Day et al.
FUTURE MICROBIOLOGY (2009)
Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
Cheng-Chung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Type II Transmembrane Serine Proteases
Thomas H. Bugge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Chawaree Chaipan et al.
JOURNAL OF VIROLOGY (2009)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Source of high pathogenicity of an avian influenza virus H5N1: Why H5 is better cleaved by furin
Panita Decha et al.
BIOPHYSICAL JOURNAL (2008)
Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors
Qiangang Yang et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2008)
Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors -: Impairment of the maturation of the E2 surface glycoprotein
Simona Ozden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens
Sergey A. Shiryaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme
Kewen Zheng et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine
Guan-Sheng Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium
Eva Böttcher et al.
JOURNAL OF VIROLOGY (2006)
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
Keng-Chang Tsai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer:: Molecular dynamics simulations and multiple X-ray structure analyses
JZ Tan et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
S Herter et al.
BIOCHEMICAL JOURNAL (2005)
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro
LL Chen et al.
JOURNAL OF VIROLOGY (2005)
The interaction of human tryptase-β with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease
T Selwood et al.
BIOCHEMISTRY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Pathway for polyarginine entry into mammalian cell
SM Fuchs et al.
BIOCHEMISTRY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
S Henrich et al.
NATURE STRUCTURAL BIOLOGY (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Furin at the cutting edge: From protein traffic to embryogenesis and disease
G Thomas
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
K Anand et al.
EMBO JOURNAL (2002)
Mutational analysis of the active centre of coronavirus 3C-like proteases
A Hegyi et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture
G Neumann et al.
JOURNAL OF VIROLOGY (2002)
Cloning and characterization of the cDNA and gene for human epitheliasin
E Jacquinet et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Polyarginines are potent furin inhibitors
A Cameron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
